Kondo T - Search Results

1

CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.

Gaud G, Achar S, Bourassa FXP, Davies J, Hatzihristidis T, Choi S, Kondo T, Gossa S, Lee J, Juneau P, Taylor N, Hinrichs CS, McGavern DB, François P, Altan-Bonnet G, Love PE. Gaud G, et al. Among authors: kondo t. Nat Immunol. 2023 Dec;24(12):2121-2134. doi: 10.1038/s41590-023-01663-2. Epub 2023 Nov 9. Nat Immunol. 2023. PMID: 37945821 Free PMC article.

2

Dendritic cells signal T cells in the absence of exogenous antigen.

Kondo T, Cortese I, Markovic-Plese S, Wandinger KP, Carter C, Brown M, Leitman S, Martin R. Kondo T, et al. Nat Immunol. 2001 Oct;2(10):932-8. doi: 10.1038/ni711. Nat Immunol. 2001. PMID: 11561182

3

Apoptotic contraction drives target cell release by cytotoxic T cells.

Sanchez EE, Tello-Lafoz M, Guo AJ, de Jesus M, Elbanna YA, Winer BY, Budhu S, Chan E, Rosiek E, Kondo T, DuSold J, Taylor N, Altan-Bonnet G, Olson MF, Huse M. Sanchez EE, et al. Among authors: kondo t. Nat Immunol. 2023 Sep;24(9):1434-1442. doi: 10.1038/s41590-023-01572-4. Epub 2023 Jul 27. Nat Immunol. 2023. PMID: 37500886 Free PMC article.

4

Co-op CARs for targeting acute myeloid leukemia.

Kondo T, Taylor N. Kondo T, et al. Cancer Cell. 2023 Nov 13;41(11):1841-1843. doi: 10.1016/j.ccell.2023.09.015. Epub 2023 Oct 12. Cancer Cell. 2023. PMID: 37832553 Free article.

5

Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.

Gaud G, Achar S, Bourassa FXP, Davies J, Hatzihristidis T, Choi S, Kondo T, Gossa S, Lee J, Juneau P, Taylor N, Hinrichs CS, McGavern DB, François P, Altan-Bonnet G, Love PE. Gaud G, et al. Among authors: kondo t. Nat Immunol. 2024 Mar;25(3):579. doi: 10.1038/s41590-023-01725-5. Nat Immunol. 2024. PMID: 38057618 No abstract available.

6

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, McFarland HF, Martin R. Bielekova B, et al. Among authors: kondo t. Nat Med. 2000 Oct;6(10):1167-75. doi: 10.1038/80516. Nat Med. 2000. PMID: 11017150 Clinical Trial.

7

Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease.

Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B, Straus SE, McFarland HF, Houghten R, Simon R, Pinilla C, Martin R. Hemmer B, et al. Among authors: kondo t. Nat Med. 1999 Dec;5(12):1375-82. doi: 10.1038/70946. Nat Med. 1999. PMID: 10581079

8

Minimal peptide length requirements for CD4(+) T cell clones--implications for molecular mimicry and T cell survival.

Hemmer B, Kondo T, Gran B, Pinilla C, Cortese I, Pascal J, Tzou A, McFarland HF, Houghten R, Martin R. Hemmer B, et al. Among authors: kondo t. Int Immunol. 2000 Mar;12(3):375-83. doi: 10.1093/intimm/12.3.375. Int Immunol. 2000. PMID: 10700472

9

Oculocutaneous albinism: developing novel antibodies targeting the proteins associated with OCA2 and OCA4.

Kondo T, Namiki T, Coelho SG, Valencia JC, Hearing VJ. Kondo T, et al. J Dermatol Sci. 2015 Jan;77(1):21-7. doi: 10.1016/j.jdermsci.2014.11.006. Epub 2014 Nov 20. J Dermatol Sci. 2015. PMID: 25530116

10

Update on the regulation of mammalian melanocyte function and skin pigmentation.

Kondo T, Hearing VJ. Kondo T, et al. Expert Rev Dermatol. 2011 Feb 1;6(1):97-108. doi: 10.1586/edm.10.70. Expert Rev Dermatol. 2011. PMID: 21572549 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,781 results

Search Page

Filters